Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity.
Zhenzhen WangYang LuYu LiuJunli MouXiaoyu LiuManling ChenYing WangYingxi XuQing RaoHaiyan XingKejing TangZheng TianBing WangWei QiMin WangShaowei QiuDongsheng XiongJian-Xiang WangPublished in: Cancer communications (London, England) (2023)